Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +2.79% | +7.44% | +3.11% |
14/05 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
14/05 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.11% | 24Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+1.48% | 2.23TCr | |
-12.64% | 2.22TCr | |
-5.10% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics : Citigroup Adjusts Ovid Therapeutics' Price Target to $4 from $4.50, Keeps Neutral Rating